356 related articles for article (PubMed ID: 30740108)
21. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
[TBL] [Abstract][Full Text] [Related]
22. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
[TBL] [Abstract][Full Text] [Related]
23. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
van der Touw W; Burrell B; Lal G; Bromberg JS
Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
[TBL] [Abstract][Full Text] [Related]
24. CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody.
Horne PH; Lunsford KE; Eiring AM; Wang Y; Gao D; Bumgardner GL
Transplantation; 2005 Aug; 80(4):514-21. PubMed ID: 16123727
[TBL] [Abstract][Full Text] [Related]
25. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
[TBL] [Abstract][Full Text] [Related]
26. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
[TBL] [Abstract][Full Text] [Related]
27. Regulation of allograft survival by inhibitory FcγRIIb signaling.
Callaghan CJ; Win TS; Motallebzadeh R; Conlon TM; Chhabra M; Harper I; Sivaganesh S; Bolton EM; Bradley JA; Brownlie RJ; Smith KG; Pettigrew GJ
J Immunol; 2012 Dec; 189(12):5694-702. PubMed ID: 23150718
[TBL] [Abstract][Full Text] [Related]
28. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
Zhang QW; Kish DD; Fairchild RL
J Immunol; 2003 Jun; 170(11):5530-7. PubMed ID: 12759430
[TBL] [Abstract][Full Text] [Related]
29. CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection.
Harper SJ; Ali JM; Wlodek E; Negus MC; Harper IG; Chhabra M; Qureshi MS; Mallik M; Bolton E; Bradley JA; Pettigrew GJ
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12788-93. PubMed ID: 26420874
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy.
Gareau AJ; Nashan B; Hirsch GM; Lee TD
J Heart Lung Transplant; 2012 Aug; 31(8):874-80. PubMed ID: 22554675
[TBL] [Abstract][Full Text] [Related]
31. Recipient natural killer cell allorecognition of passenger donor lymphocytes and its effect on adaptive alloimmunity after transplantation.
Ali J; Harper I; Bolton E; Bradley JA; Pettigrew G
Lancet; 2015 Feb; 385 Suppl 1():S18. PubMed ID: 26312840
[TBL] [Abstract][Full Text] [Related]
32. Effect of alloantibodies on corneal allograft survival.
Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
[TBL] [Abstract][Full Text] [Related]
33. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
34. The rejection mechanism of rat pancreaticoduodenal allografts with a class I MHC disparity.
Yamamoto S; Ito T; Nakata S; Nozaki S; Uchikoshi F; Shirakura R; Kamiike W; Miyata M; Matsuda H
Transplantation; 1994 Apr; 57(8):1217-22. PubMed ID: 7909966
[TBL] [Abstract][Full Text] [Related]
35. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection.
Noorchashm H; Reed AJ; Rostami SY; Mozaffari R; Zekavat G; Koeberlein B; Caton AJ; Naji A
J Immunol; 2006 Dec; 177(11):7715-22. PubMed ID: 17114442
[TBL] [Abstract][Full Text] [Related]
36. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
Bishop DK; Shelby J; Eichwald EJ
Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
[TBL] [Abstract][Full Text] [Related]
37. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody.
Morton AL; Bell EB; Bolton EM; Marshall HE; Roadknight C; McDonagh M; Bradley JA
Eur J Immunol; 1993 Sep; 23(9):2078-84. PubMed ID: 8103742
[TBL] [Abstract][Full Text] [Related]
38. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
[TBL] [Abstract][Full Text] [Related]
39. Costimulatory blockade molecules and B-cell-mediated immune response: current knowledge and perspectives.
Leibler C; Thiolat A; Elsner RA; El Karoui K; Samson C; Grimbert P
Kidney Int; 2019 Apr; 95(4):774-786. PubMed ID: 30711200
[TBL] [Abstract][Full Text] [Related]
40. Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts.
Gaughan A; Wang J; Pelletier RP; Nadasdy T; Brodsky S; Roy S; Lodder M; Bobek D; Mofatt-Bruce S; Fairchild RL; Henry ML; Hadley GA
Am J Transplant; 2014 Feb; 14(2):284-94. PubMed ID: 24410909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
